Commissioners told to slash hospital spend on high-cost drugs

GP commissioners must urgently bring 'accelerating' hospital spend on high-cost drugs under control, the DH has warned.

Spending: GP commissioners urged to cut hospital drug costs

The department said the NHS may be wasting millions of pounds a year because hospitals and providers are not incentivised to cut the cost of drugs that fall outside of the Payment by Results tariff.

Ministers want GP commissioners to work with hospitals to reduce the bill for high-cost ‘homecare’ treatments, which now cost the NHS at least £1.25bn. This figure is rising by 20% per year.

But last year University Hospital Southampton NHS Foundation Trust saved around £4m by reviewing its homecare spending, suggesting similar efforts across the NHS could save hundreds of millions of pounds.

Homecare treatments are hospital-prescribed medicines supplied directly to patients’ homes. Prices are negotiated locally because they fall outside of the national Payment by Results tariff.

But a DH report produced as part of the NHS efficiency savings drive suggested the NHS may be wasting money ‘paying for more expensive treatments where equally effective but cheaper alternatives are available’. It said this may be due to the lack of a financial incentive for commissioners and providers to reduce treatment costs.

The DH has appointed Mark Hackett, chief executive of University Hospital Southampton and author of a 2011 report into homecare medicines, to lead a project aiming ‘to maximise efficiency and value for NHS budgets’ relating to homecare treatments.

In a letter to hospital chiefs, he warned that these costs are set to accelerate unless the NHS takes action.

He added: ‘We will be seeking to engage with clinical commissioning groups (CCGs) to ensure that these efficiencies are maximised in 2013/14.’

The DH says the report will help commissioners and providers when ensuring patients can access NICE-approved treatments under the NHS Constitution.

Earlier this year a GP magazine investigation found the NHS may fail to hit efficiency targets because hospitals' efforts to control drug spending are decades behind those in primary care.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins


Already registered?

Sign in

Just published

BMA Scotland GP committee chair Dr Andrew Buist

General practice in Scotland 'in serious trouble', warns BMA Scotland GP chair

General practice in Scotland has reached a tipping point, with demand far outstripping...

Hospital entrance

NHS England issues warning over norovirus and rising winter pressures

Almost three times as many people were in hospital with norovirus last week compared...

BMA Northern Ireland GP committee chair Dr Alan Stout

Northern Ireland GPs face deepest-ever crisis as practices hand back contracts

Northern Ireland's GP leader has warned that general practice in the region is facing...

GP consulting room

GP appointments hit record high of over 34m in October

GP practices delivered a record 34.3m appointments in October this year excluding...

GP consultation

New contract that enforces continuity would make GPs and patients safer, says watchdog

A new GP contract that makes continuity of care an 'essential requirement' for practices...

GP receptionist on the phone

Some practices to receive funding to upgrade digital phone systems

GP practices whose digital phone systems do not meet new NHS England standards will...